Uncategorized

POXEL SA announced its participation at the JMP Securities Life Science Conference, to be held in New York, NY, Monday, May 15, and Tuesday, May 16, 2023.

Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the ASGCT Annual Meeting taking place on May 16-20, 2023, in Los Angeles, USA.

Biophytis SA is announcing it has successfully completed its fundraising round for a total amount of €2.3M through capital increases with cancellation of the shareholders’ preferential subscription rights to the benefit of professional investors up to €1.9M on the one hand, and to the benefit of individual investors via the PrimaryBid platform up to €0.4M

Scorpius BioManufacturing, a Texas-based biologics contract development and manufacturing organization, announced the appointment of Joe Payne as Vice President, Quality and Regulatory Affairs.

Pharming Group N.V. presents its preliminary, unaudited financial report for the first quarter ended March 31, 2023.

Otsuka Pharmaceutical, Co. Ltd. and Lundbeck LLC announce the U.S. Food and Drug Administration has approved the supplemental New Drug Application of REXULTI® for use in the treatment of agitation associated with dementia due to Alzheimer’s disease.

By selling its Brand New Day and Central Health MA plans, Bright Health, which would no longer be in the insurance business following the sale, intends to focus on its consumer care products, CFO Cathy Smith said.

The insurer plans to exit the state this year after consistently recording medical loss ratios over 100%, executives said on an earnings call.

Sarepta’s biomarker-based data “do not provide unambiguous evidence” of the therapy’s likely benefit for Duchenne muscular dystrophy patients, according to the regulatory agency.

The agreement is expected to increase access to next-generation sequencing for patients in more than 30 countries.